Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial.
Ulrich MrowietzJonathan BarkerCurdin ConradDenis JullienPaolo GisondiAndrea FlowerJyotsna ReddyMaria ParisHernan PicardShauna JardonMatthias AugustinPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Apremilast significantly improved skin-related QoL in patients with limited skin involvement with plaque psoriasis in special areas and highly impaired QoL. The safety profile was consistent with prior apremilast studies.